GLP-1 receptor agonists, including semaglutide, commonly cause gastrointestinal adverse effects, and some patients report belching with a sulfur odor, though "sulfur burps" are not specifically listed in FDA prescribing information
Heres a good podcast of the story behind GLP1RAs: Novo Nordisk (Ozempic): The Complete History and Strategy 3 Likes AgentSmith May 21, 2024, 3:08pm #13 This MyPhenome test strikes me as unnecessary and another opportunistic money grab based on the false premise that the only option is to pay $1200 a month out of pocket for name brand drugs
GLP-1 GLP-1GLP-1GLP-1 12351525134 28GLP-1 1 GLP-1 3
3 Previous randomized control trials of semaglutide in diabetic and non-diabetic populations have suggested that non-diabetic patients lose more weight than diabetic patients when prescribed semaglutide, but those studies do not represent real-world data and did not evaluate doses lower than 2.4 mg
Also known as GLP-1 agonists, these drugs work by mimicking a hormone that regulates appetite and blood glucose control
Long-term success comes from the metabolic reprogramming that occurs when GLP pathways remain consistently activated, helping maintain results even after you complete your initial treatment protocol